Showing results (311-320 of 378) with videos related to

Sort By:
Pageof 38
Ebiomedicine|February 22, 2024
A hypoxia biomarker does not predict benefit from giving chemotherapy with radiotherapy in the BC2001 randomised controlled trialTim A D Smith, Catharine M L West, Nuradh Joseph, et al.
The Lancet. Oncology|November 3, 2015
Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trialAnna Wilkins, Helen Mossop, Isabel Syndikus, et al.
The Lancet. Oncology|January 18, 2011
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trialChristopher M Nutting, James P Morden, Kevin J Harrington, et al.
Clinical and Translational Radiation Oncology|October 14, 2022
PEARLS - A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA-avid pelvic and/or para-aortic lymph nodes at presentationJulia Murray, Clare Cruickshank, Thomas Bird, et al.
Clinical and Translational Radiation Oncology|February 24, 2026
PACE-NODES: A phase III randomised trial of 5 fraction prostate stereotactic body radiotherapy (SBRT) versus 5 fraction prostate and pelvic nodal SBRTAngela Pathmanathan, Suneil Jain, John Staffurth, et al.
BMJ Open|September 5, 2019
Photodynamic versus white light-guided treatment of non-muscle invasive bladder cancer: a study protocol for a randomised trial of clinical and cost-effectivenessZafer Tandogdu, Rebecca Lewis, Anne Duncan, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2020
Clinical Outcomes of a Randomized Trial of Adaptive Plan-of-the-Day Treatment in Patients Receiving Ultra-hypofractionated Weekly Radiation Therapy for Bladder CancerRobert Huddart, Shaista Hafeez, Rebecca Lewis, et al.
Lancet (London, England)|May 19, 2009
Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trialPaul Ellis, Peter Barrett-Lee, Lindsay Johnson, et al.
International Journal of Radiation Oncology, Biology, Physics|January 3, 2023
Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International ConsensusSimon K B Spohn, Cédric Draulans, Amar U Kishan, et al.
NEJM Evidence|February 6, 2024
A Randomized Trial of PHOTOdynamic Surgery in Non-Muscle-Invasive Bladder CancerRakesh Heer, Rebecca Lewis, Thenmalar Vadiveloo, et al.
Pageof 38